Substance abuse advisory:
naltrexone.
The Center for Substance Abuse Treatment has released the Substance
Abuse Treatment Advisory: Naltrexone for Extended-Released Injectable
Suspension for Treatment of Alcohol Dependence (SMA07-4267). The
advisory addresses questions that treatment providers may have about
injectable naltrexone. To order a free copy or to view the advisory in
PDF format, visit http://ncadistore.samhsa.gov/catalog/productDetails.aspx?ProductID=17649.
COPYRIGHT 2007 International Medical News
Group Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2007 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.
Browse by Journal Name: